{
    "doi": "https://doi.org/10.1182/blood.V118.21.711.711",
    "article_title": "Polymorphisms in Antitrombin (SERPINC1) and Tissue Factor Pathway Inhibitor (TFPI) Genes Are Associated with Recurrent Pregnancy Loss ",
    "article_date": "November 18, 2011",
    "session_type": "331. Pathophysiology of Thrombosis: Venous Thromboembolism - Diagnosis and Management",
    "abstract_text": "Abstract 711 Background: Recurrent pregnancy loss (RPL) is a multifactorial condition. The effects of antithrombin (SERPINC1), protein C (PROC), thrombomodulin (THBD) and tissue factor pathway inhibitor (TFPI) gene polymorphisms in the risk of having RPL are unknown. Aims: To determine the effects of SERPINC1, PROC, THBD and TFPI gene polymorphisms in the risk of having RPL. Methods: One hundred and fifteen non-pregnant women with three consecutive losses prior to 20 weeks of pregnancy without carrying a fetus to viability (primary RPL) and 253 healthy fertile non-pregnant women who had at least two children and no known pregnancy losses were studied. The PROC (rs1799809 and rs1799808), SERPINC1 (rs2227589), THBD (rs1042579) and TFPI (rs10931292 and rs8176592) gene polymorphisms were detected respectively by Real Time PCR. Results: No difference was observed among the genotypes frequencies for PROC 2418A>G, PROC 2405C>T, THBD 1418C>T and TFPI T-33C polymorphisms in two groups ( Table 1 , P>0.05). However, the carriers of 140T allele (CT + TT genotypes) for SERPINC1 C+140T polymorphism had 1.73 (95% CI: 1.00 \u2013 2.99) times risk of having RPL. Furthermore, the carriers of TC + CC genotypes for TFPI T-287C polymorphism had a protection effect of having RPL (OR: 0.48, 95% CI 0.27\u2013 0.86). Conclusions: The variant of SERPINC1 C+140T polymorphism is associated with higher risk of having RPL while the variant of TFPI T-287C polymorphism is associated with a protection effect. Table 1 \u2013 Genotypes distributions of investigated SNPs  Polymorphism . SNP ID . Chr . Chr position . Genotypes . RPL group . Control group . OR (CI 95%) . P valor . PROC 2418A>G rs1799809 2 128175875 AA 37 (32.5) 88 (34.8) 1.00      AG + GG 77 (67.5) 165 (65.2) 1.11 (0.69\u20131.78) 0.663          PROC 2405C>T rs1799808 2 128175862 CC 42 (36.8) 87 (34.4) 1.00      CT + TT 72 (63.2) 166 (65.6) 0.90 (0.57\u20131.42) 0.649          SERPINC1 C+140T rs2227589 1 173886216 CC 86 (75.4) 213 (84.2) 1.00      CT + TT 28 (24.6) 40 (15.8) 1.73 (1.00\u20132.99) 0.047          THBD c.1418C>T rs1042579 20 23028724 CC 87 (76.3) 195 (77.1) 1.00      CT + TT 27 (23.7) 58 (22.9) 1.04 (0.62\u20131.76) 0.873          TFPI T-287C rs10931292 2 188419479 TT 97 (85.1) 185 (73.1) 1.00      TC + CC 17 (14.9) 68 (26.9) 0.48 (0.27\u20130.86) 0.013          TFPI T-33C rs8176592 2 188332692 TT 51 (44.7) 114 (45.1) 1.00      TC + CC 63 (55.3) 139 (54.9) 1.01 (0.65\u20131.58) 0.954 Polymorphism . SNP ID . Chr . Chr position . Genotypes . RPL group . Control group . OR (CI 95%) . P valor . PROC 2418A>G rs1799809 2 128175875 AA 37 (32.5) 88 (34.8) 1.00      AG + GG 77 (67.5) 165 (65.2) 1.11 (0.69\u20131.78) 0.663          PROC 2405C>T rs1799808 2 128175862 CC 42 (36.8) 87 (34.4) 1.00      CT + TT 72 (63.2) 166 (65.6) 0.90 (0.57\u20131.42) 0.649          SERPINC1 C+140T rs2227589 1 173886216 CC 86 (75.4) 213 (84.2) 1.00      CT + TT 28 (24.6) 40 (15.8) 1.73 (1.00\u20132.99) 0.047          THBD c.1418C>T rs1042579 20 23028724 CC 87 (76.3) 195 (77.1) 1.00      CT + TT 27 (23.7) 58 (22.9) 1.04 (0.62\u20131.76) 0.873          TFPI T-287C rs10931292 2 188419479 TT 97 (85.1) 185 (73.1) 1.00      TC + CC 17 (14.9) 68 (26.9) 0.48 (0.27\u20130.86) 0.013          TFPI T-33C rs8176592 2 188332692 TT 51 (44.7) 114 (45.1) 1.00      TC + CC 63 (55.3) 139 (54.9) 1.01 (0.65\u20131.58) 0.954 Chr: chromosome; SNP: single nucleotide polymorphisms; RPL: recurrent pregnancy loss. The data are absolute (relative) frequencies. Financing: Fundac\u0327a\u0303o de Amparo a\u0300 Pesquisa do Estado de Sa\u0303o Paulo (FAPESP 2007/57605-0) View Large Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "abortion, habitual",
        "genes",
        "polymorphism",
        "tissue factor pathway inhibitor",
        "protein c",
        "chief complaint",
        "antithrombin iii",
        "antithrombins",
        "polymerase chain reaction",
        "thrombomodulin"
    ],
    "author_names": [
        "Elvira Maria Guerra-Shinohara, PhD",
        "Juliano Felix Bertinato",
        "Kelma Cordeiro da Silva Giusti",
        "Fernanda Midori Seino",
        "Carolina Tosin Bueno",
        "Mario Henrique Burlacchini de Carvalho, MD, PhD",
        "Anto\u0302nio Gomes Amorim Filho, MD",
        "Marcelo Zugaib, MD, PhD",
        "Carlos S Chiattone, MD, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Elvira Maria Guerra-Shinohara, PhD",
            "author_affiliations": [
                "Clinical Chemistry and Toxicologic, Sao Paulo University, Sao Paulo, Brazil, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Juliano Felix Bertinato",
            "author_affiliations": [
                "Clinical Chemistry and Toxicologic, University of Sa\u0303o Paulo, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kelma Cordeiro da Silva Giusti",
            "author_affiliations": [
                "Clinical Chemistry and Toxicologic, Sa\u0303o Paulo University, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fernanda Midori Seino",
            "author_affiliations": [
                "Clinical Chemistry and Toxicologic, Sa\u0303o Paulo University, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carolina Tosin Bueno",
            "author_affiliations": [
                "Clinical Chemistry and Toxicologic, Sa\u0303o Paulo University, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Henrique Burlacchini de Carvalho, MD, PhD",
            "author_affiliations": [
                "Obstetrics and Gynecology Departament of Clinical Hospital of Medicine School, University of Sa\u0303o Paulo, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anto\u0302nio Gomes Amorim Filho, MD",
            "author_affiliations": [
                "Obstetrics and Gynecology Departament of Clinical Hospital of Medicine Schoo, Sao Paulo University, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marcelo Zugaib, MD, PhD",
            "author_affiliations": [
                "Obstetrics and Gynecology Departament of Clinical Hospital of Medicine Schoo, Sao Paulo University, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos S Chiattone, MD, PhD",
            "author_affiliations": [
                "Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-19T18:52:14",
    "is_scraped": "1"
}